Study of Top Investment Opportunities in Indian Biotechnology Sector
Every opportunity for investing is a new door that may lead to success or disaster. One must study the structure and growth of the company before making any move. These new companies in India present an opportunity for investment because they have enormous growth potential. Here we take a look at the top Biotechnology companies and explore their strong and weak points.
The largest biotech company has its focus on reducing the cost of therapy for chronic diseases like cancer and diabetes. Among their innovations, the indigenous variety of recombinant insulin for humans and monoclonal antibody for cancer of the neck and head stand out. This is one of the new funded Biotechnology companies in India in which one could invest. Its main growth areas are novel molecules, branded formulations, biosimilars, and small molecules. It is the first Indian company to get funding from the US for its proprietary technologies. For the past 18 years, it has pursued clinical research through its clinical research organization, Clinigene. The founder Ms.Mazumdar Shaw is worth $1.2 billion.
This is one of the oldest pharmaceutical companies in India. Since 1924, it has a global value of £26.5 billion. It gives research-based healthcare for areas such as gynaecology, oncology, dermatology, respiratory and cardiovascular diseases, diabetes, and more. It offers vaccines for tetanus, diphtheria, chicken pox, hepatitis A, cervical cancer, rotavirus, hepatitis B, and more.
Indian Immunologicals, Hyderabad
The National Dairy Development Board created Indian Immunologicals Ltd to improve the health of the livestock in India. Since 1982, it has been making animal vaccines and is one of the largest such plants in the world. They also make adult and paediatric vaccines. It has an annual turnover of INR 450 crore for the fiscal year 2014 with an annual growth rate of 25 percent.
Serum Institute of India, Pune
One of the largest producers of vaccines in the world, Serum Institute of India makes vaccines for Rubella, Mumps, Measles, r-Hepatitis B, BCG, Hib, and more. The company has revenue of $714 million for the year 2016-17. Of the new Biotechnology companies in India, this is one that stands apart. This company set up the Serum BioPharma Park, the first biotech special economic zone (SEZ). Due to its efforts, the country has become self-sufficient in DTP vaccines, anti-snake venom serum, and tetanus antitoxin serum among others.
Wockhardt Limited, Mumbai
This pharmaceutical and biotechnological organization provides high-quality affordable medicines to the people of India. It has associates from 21 different nations. With headquarters in Mumbai, it has manufacturing units in France, US, Ireland, and the UK. More than half its revenue comes from Europe. Its annual turnover stood at $540 million and has a market capitalization of $3.1 billion. Other than vaccines and pharmaceutical ingredients, it also produces nutritional products, formulations, and biopharmaceuticals.
Investment for the businessman is only the beginning. Compile the list of investments you would like by going through the list above. It is always good to see new investments since that will spur growth.